![Orientations provisoires sur l'utilisation du test rapide de l'antigène COVID-19 d'Abbott Panbio, RMTC 47(1) - Canada.ca Orientations provisoires sur l'utilisation du test rapide de l'antigène COVID-19 d'Abbott Panbio, RMTC 47(1) - Canada.ca](https://www.canada.ca/content/dam/phac-aspc/images/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/2021-01/ccdrv47i01a04f-fra.png)
Orientations provisoires sur l'utilisation du test rapide de l'antigène COVID-19 d'Abbott Panbio, RMTC 47(1) - Canada.ca
![Abbott Highlights Rapid Diagnostic Platforms to Complement Centralized RT-PCR Testing at ECCMID 2022 - ECCMID 2022 - mobile.Labmedica.com Abbott Highlights Rapid Diagnostic Platforms to Complement Centralized RT-PCR Testing at ECCMID 2022 - ECCMID 2022 - mobile.Labmedica.com](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2022-04-26/SDD-294792604.jpg)
Abbott Highlights Rapid Diagnostic Platforms to Complement Centralized RT-PCR Testing at ECCMID 2022 - ECCMID 2022 - mobile.Labmedica.com
![Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection - eClinicalMedicine Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection - eClinicalMedicine](https://www.thelancet.com/cms/asset/fa3de941-9e43-43ad-9d99-1da6ed4b3b54/gr1.jpg)